Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

The Novavax vaccine, which Pavia said is a protein vaccine rather than ... but only 15.9% received the bivalent booster. The ...

Novavax has updated its protein subunit vaccine to target XBB.1.5 as well ... Disease Organization at the University of ...

But it's not to go sightseeing or shopping. Wilhelm, who suffers from severe rheumatoid arthritis, hopes to get the updated Novavax COVID-19 vaccine, which won't be available in Canada as part of ...

Novavax (NVX-CoV2373) is a vaccine used to reduce the risk of serious infection from the virus that causes COVID-19. Novavax can cause side effects that range from mild to serious. Examples ...

Here's what to know about the latest vaccines, who needs them and how they ... authorization last week to an updated version of the Novavax shot, which includes a "monovalent (single) component ...

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...

Novavax, Inc., a Gaithersburg-based company advancing protein-based vaccines with its Matrix-M™ adjuvant, Tuesday announced its updated vaccine (Adjuvanted, 2024-2025 Formula, NVX-CoV2705 ...